Removing Home Hazards for Older Adults in Affordable Housing

Sponsor
Washington University School of Medicine (Other)
Overall Status
Completed
CT.gov ID
NCT03780777
Collaborator
US Department of Housing and Urban Development (U.S. Fed)
524
1
1
25.8
20.3

Study Details

Study Description

Brief Summary

The investigators will conduct a hybrid effectiveness/implementation trial to simultaneously establish the effectiveness of home hazard removal in affordable housing in order to reduce falls, and conduct a process evaluation of how the intervention works in the context of low-income senior apartments.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Home Hazard Removal
N/A

Detailed Description

The investigators, in collaboration with the community partner, will offer the program to all building residents in select low-income senior apartments. The eligibility criteria include a self-report of one or more falls in the preceding 12 months, a fear of falling, or unsteadiness while standing or walking. The investigators will screen residents and determine their risk for falling. Residents who are high risk will be referred to licensed occupational therapy practitioners for baseline assessments and home hazard removal. Residents will be re-assessed at 3 months. All assessments will be conducted in the residents' apartment buildings. Outcomes (falls, program evaluation) will be collected by our community partner.

Study Design

Study Type:
Interventional
Actual Enrollment :
524 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Removing Home Hazards for Older Adults in Affordable Housing
Actual Study Start Date :
Apr 15, 2019
Actual Primary Completion Date :
Jun 9, 2021
Actual Study Completion Date :
Jun 9, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Home Hazard Removal Group

A tailored home-modification (home-hazard removal) intervention for residents with a high fall risk, delivered in the home by occupational therapists over one to two visits and with a booster session at three months.

Behavioral: Home Hazard Removal
Removal of home barriers or hazards

Outcome Measures

Primary Outcome Measures

  1. Resident enrollment in home hazard removal intervention [609 days]

    Participation measured by percentage of eligible building residents enrolled

  2. Program fidelity [609 days]

    Visit-by-visit checklist and calculation of the dose of the intervention received (number of minutes delivered)

Secondary Outcome Measures

  1. Number of falls [609 days]

    Prospective monthly reporting of falls using an automated phone system

  2. Cost per fall prevented [609 days]

    Final prescription and invoice (materials)

  3. Adherence to home hazard removal intervention recommendations [609 days]

    Recommendations used/total at 3 months or cause of abandonment

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Residents who live in any of the eligible section 202 low-income senior apartment units managed by our community partner
Exclusion Criteria:
  • Individuals who do not reside in any of the eligible units

Contacts and Locations

Locations

Site City State Country Postal Code
1 Washington University School of Medicine Saint Louis Missouri United States 63108

Sponsors and Collaborators

  • Washington University School of Medicine
  • US Department of Housing and Urban Development

Investigators

  • Principal Investigator: Susan Stark, PhD, Washington University School of Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT03780777
Other Study ID Numbers:
  • 201811108
  • MOHHU0040-17
First Posted:
Dec 19, 2018
Last Update Posted:
Aug 6, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Washington University School of Medicine

Study Results

No Results Posted as of Aug 6, 2021